News & Updates

Early recognition and management of emerging palliative care (PC) needs, particularly psychospiritual distress, is crucial for enhancing health-related quality of life (HRQoL) for patients with peripheral neurologic diseases (PNDs), a study by the University of Hong Kong (HKU) has found.  

In the management of diabetes, users of glucagon-like peptide-1 receptor agonists (GLP-1RAs) appear to have a lower risk of all-cause dementia compared with users of other glucose-lowering medications, according to a systematic review and meta-analysis.

COVID-19 pandemic and pandemic-related events do not appear to have resulted in cognitive decline in middle-aged women, according to a study.

A recent study found that self-perceived stress may increase the risk of early-onset cryptogenic ischaemic stroke (CIS) in young adults, particularly women.

Continuous dopamine D2 receptor blockade does not appear to increase the risk of breakthrough psychosis in patients with first-episode schizophrenia, as shown in a study.

Treatment with inebilizumab significantly improved generalized myasthenia gravis (gMG) symptoms, as shown by a greater reduction in MG-Activities of Daily Living (MG-ADL) scores, among patients who were acetylcholine receptor antibody-positive (AChR-Ab+) or muscle-specific kinase antibody-positive (MuSK-Ab+), according to the phase III MINT* trial presented at AAN 2025.

A wrist-worn wearable that harnesses artificial intelligence (AI) for noninvasive modulation of the nervous system appears beneficial in patients with essential tremor, enabling them to regain greater control over their upper limb movements for everyday activities.